Pfizer Inc (NYSE:PFE)

28.92
Data as of Aug 22
 +0.10 / +0.35%
Today’s Change
27.76
Today|||52-Week Range
32.96
-5.58%
Year-to-Date
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Aug 22 / Zacks.com
Stock Market News for August 15, 2014 - Market News
Aug 15 / Zacks.com
3 Reasons Bristol-Myers Squibb's Stock Could Rise
Aug 22 / MotleyFool.com
Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog
Aug 14 / Zacks.com
3 Stocks Reiterated As A Buy: PFE, SLB, V
Aug 22 / TheStreet.com
7 things you absolutely must know about corporate taxes
Aug 14 / CNNMoney.com
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Resea...
Aug 22 / Zacks.com
Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog
Aug 13 / Zacks.com
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Aug 21 / Benzinga
Big businesses still fighting for same-sex marriage
Aug 12 / CNNMoney.com
Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog
Aug 21 / Zacks.com
UBS AG Contemplates $4.5B Bond Offerings in U.S. - Analyst Blog
Aug 12 / Zacks.com
US TV takeovers threaten UK creative economy, says C4 chief
Aug 21 / FT.com
5 Things Pfizer Inc.'s Management Wants You to Know
Aug 12 / MotleyFool.com
Build A bWhatever Happensb Portfolio Now
Aug 21 / Investing Channel
US groups ponder the great tax escape
Aug 08 / FT.com
Pfizer Could Revive AstraZeneca Bid As Early As Tuesday
Aug 21 / Benzinga
Tesla settles dispute with trademark troll in China
Aug 08 / CNNMoney.com
Drugmaker link-up puts Astra on top
Aug 21 / FT.com
How to stay safe in a scary market
Aug 07 / CNNMoney.com
Why AstraZeneca (AZN) Stock Is Higher Today
Aug 21 / TheStreet.com
Shire shares slide on fears of 'tax inversion' clampdown
Aug 06 / FT.com
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Aug 20 / Zacks.com
Corporate acquirors take early aim at their target's investors
Aug 05 / FT.com
Baxter International Expands Dialyzers Facility in Alabama - Analyst Blog
Aug 20 / Zacks.com
AstraZeneca chairman Leif Johansson defends Pfizer rebuff
Aug 04 / FT.com
What next for M&As now the bubble has burst?
Aug 20 / FT.com
AstraZeneca raises full-year earnings guidance
Jul 31 / FT.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
Aug 19 / Zacks.com
Pfizer refuses to rule out tax inversion deals
Jul 30 / FT.com
A Beaten-Up Pharma With a Big Upside
Aug 19 / Investing Channel
AstraZeneca to bolster respiratory drugs with Almirall deal
Jul 30 / FT.com
3 Reasons Pfizer Inc.'s Stock Could Rise
Aug 19 / MotleyFool.com
Stocks: 5 things to know before the open
Jul 29 / CNNMoney.com
DoJ closes AstraZeneca probe without bringing charges
Aug 19 / FT.com
Consumer and pharma groups swap assets
Jul 28 / FT.com
3 Stocks Reiterated As A Buy: PFE, XOM, REGN
Aug 18 / TheStreet.com
Obama's dilemma over tax inversions
Jul 24 / FT.com
Pfizer Announces Submission of Palbociclib New Drug Application To The FDA
Aug 18 / Benzinga
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.